Trial site
Brigham and Women's Hospital Vaccine CRS (BWH VCRS)
Boston, Massachusetts 02115, United StatesNot linked to an institution yet
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Phase
- Phase 15 trials
- Phase 21 trial
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Recruiting2 trials
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)6 trials
Running trials
Recruiting
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
NCT06665646· Phase 1· National Institute of Allergy and Infectious Diseases (NIAID)· Source
Contact: Jose Licona, MD
Recruiting
Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
NCT06796686· Phase 1· National Institute of Allergy and Infectious Diseases (NIAID)· Source
Contact: Jose Licona
Active, not recruiting
A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV
NCT06812494· Phase 2· National Institute of Allergy and Infectious Diseases (NIAID)· Source
Active, not recruiting
Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 16055 NFL Delta Gly4 Env Protein Trimer and Trimer 4571 Combined With 3M-052-AF + Alum Adjuvant and Ad4-Env145NFL Viral Particles as Heterologous Prime-boost Regimens in Adult Participants Without HIV.
NCT06332339· Phase 1· National Institute of Allergy and Infectious Diseases (NIAID)· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error